Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Athira Pharma, Inc. (ATHA)
:ATHA
Holding ATHA?
Track your performance easily
Athira Pharma (ATHA) Ownership Overview
10.59% Insiders
5.39% Mutual Funds
0.09% Other Institutional Investors
8.00% ETFs
75.93% Public Companies and Individual Investors
The ownership structure of Athira Pharma (ATHA) stock is a mix of institutional, retail, and individual investors. Approximately 13.48% of the company’s stock is owned by Institutional Investors, 10.59% is owned by Insiders, and 75.93% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
| Sep 05, 2024 | Mark Worthington Gc And Cco | xxxxxxxxxxxxx | $1414 |
| Sep 05, 2024 | Kevin Church Cso | xxxxxxxxxxxxx | $1414 |
| Sep 05, 2024 | Mark James Litton President & Ceo,director | xxxxxxxxxxxxx | $2818 |
| Sep 05, 2024 | Andrew Gengos Cfo And Chief Business Officer | xxxxxxxxxxxxx | $712 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
| Sep 30, 2024 | xxxxxxxxxxxxx | $20070 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 5,402,964 | Institution | 13.97% | 2,923,004 | |
| 3,153,807 | Institution | 8.16% | 1,706,210 | |
| 3,114,805 | Insider | 8.06% | 1,685,110 | |
| 1,573,128 | Institution | 4.07% | 851,062 | |
| 1,524,656 | Institution | 3.94% | 824,839 | |
| 1,492,792 | Institution | 3.86% | 807,600 | |
| 290,081 | Institution | 0.75% | 156,934 | |
| 262,280 | Insider | 0.68% | 141,893 | |
| 148,615 | Insider | 0.38% | 80,401 | |
| 130,761 | Insider | 0.34% | 70,742 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 1,573,128 | Institution | 4.07% | 851,062 | |
| 290,081 | Institution | 0.75% | 156,934 | |
| 88,893 | Institution | 0.23% | 48,091 | |
| 73,545 | Institution | 0.19% | 39,788 | |
| 26,677 | Institution | 0.07% | 14,432 | |
| 9,760 | Institution | 0.03% | 5,280 | |
| 9,066 | Institution | 0.02% | 4,905 | |
| 6,623 | Institution | 0.02% | 3,583 | |
| 4,153 | Institution | 0.01% | 2,247 | |
| 1,185 | Institution | <0.01% | 641 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 1,492,792 | Institution | 3.86% | 794,165 | |
| 1,072,638 | Institution | 2.77% | 702,792 | |
| 452,018 | Institution | 1.17% | 296,162 | |
| 76,586 | Institution | 0.20% | 41,502 |
FAQ
Who Owns Athira Pharma, Inc. (ATHA)?
According to the latest TipRanks data, approximately 0.09% of the company's stock is held by institutional investors, 10.59% is held by insiders, and 75.93% is held by retail investors.
What percentage of Athira Pharma, Inc. (ATHA) stock is held by institutional investors?
According to the latest TipRanks data, approximately 0.09% of Athira Pharma, Inc. (ATHA) stock is held by institutional investors.
What percentage of Athira Pharma, Inc. (ATHA) stock is held by retail investors?
According to the latest TipRanks data, approximately 75.93% of Athira Pharma, Inc. (ATHA) stock is held by retail investors.
Who owns the most shares of Athira Pharma, Inc. (ATHA)?
Joseph Edelman owns the most shares of Athira Pharma, Inc. (ATHA).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.